Sakar Healthcare signed an agreement with Zydus Lifesciences for supply of oncology products across GCC countries and emerging markets. The company stated that it has now signed 40 global anti-cancer agreements. FY26 revenue rose 42% to ₹251.73 crore, while net profit increased 74%. The company also secured multiple EMA and MHRA approvals.